Literature DB >> 23212455

In vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity.

William E Fantegrossi1, Brenda M Gannon, Sarah M Zimmerman, Kenner C Rice.   

Abstract

In recent years, synthetic analogues of naturally occurring cathinone have emerged as psychostimulant-like drugs of abuse in commercial 'bath salt' preparations. 3,4-Methylenedioxypyrovalerone (MDPV) is a common constituent of these illicit products, and its structural similarities to the more well-known drugs of abuse 3,4-methylenedioxymethamphetamine (MDMA), and methamphetamine (METH) suggest that it may have similar in vivo effects to these substances. In these studies, adult male NIH Swiss mice were trained to discriminate 0.3 mg/kg MDPV from saline, and the interoceptive effects of a range of substitution doses of MDPV, MDMA, and METH were then assessed. In separate groups of mice, surgically implanted radiotelemetry probes simultaneously monitored thermoregulatory and locomotor responses to various doses of MDPV and MDMA, as a function of ambient temperature. We found that mice reliably discriminated the MDPV training dose from saline and that cumulative doses of MDPV, MDMA, and METH fully substituted for the MDPV training stimulus. All three drugs had similar ED(50) values in this procedure. Stimulation of motor activity was observed following administration of a wide range of MDPV doses (1-30 mg/kg), and the warm ambient temperature potentiated motor activity and elicited profound stereotypy and self-injurious behavior at 30 mg/kg. In contrast, MDPV-induced hyperthermic effects were observed in only the warm ambient environment. This pattern of effects is in sharp contrast to MDMA, where ambient temperature interacts with thermoregulation, but not locomotor activity. These studies suggest that although the interoceptive effects of MDPV are similar to those of MDMA and METH, direct effects on thermoregulatory processes and locomotor activity are likely mediated by different mechanisms than those of MDMA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23212455      PMCID: PMC3572465          DOI: 10.1038/npp.2012.233

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  54 in total

1.  Effects of cocaine and morphine under mixed-ratio schedules of food delivery: support for a behavioral momentum analysis.

Authors:  A Poling; T Byrne; L Christian; M G Lesage
Journal:  Pharmacol Biochem Behav       Date:  2000-06       Impact factor: 3.533

2.  Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order.

Authors: 
Journal:  Fed Regist       Date:  2011-10-21

3.  Calcium channel activation and self-biting in mice.

Authors:  H A Jinnah; S Yitta; T Drew; B S Kim; J E Visser; J D Rothstein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

4.  Pharmacological characterization of designer cathinones in vitro.

Authors:  L D Simmler; T A Buser; M Donzelli; Y Schramm; L-H Dieu; J Huwyler; S Chaboz; M C Hoener; M E Liechti
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

5.  SA 4503 attenuates cocaine-induced hyperactivity and enhances methamphetamine substitution for a cocaine discriminative stimulus.

Authors:  Kelli R Rodvelt; Susan Z Lever; John R Lever; Lucas R Blount; Kuo-Hsien Fan; Dennis K Miller
Journal:  Pharmacol Biochem Behav       Date:  2010-11-27       Impact factor: 3.533

6.  Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice.

Authors:  Helen N Panas; Laurie J Lynch; Eric J Vallender; Zhihua Xie; Guo-Lin Chen; Spencer K Lynn; Thomas S Scanlan; Gregory M Miller
Journal:  J Neurosci Res       Date:  2010-07       Impact factor: 4.164

7.  Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Lucas R Watterson; Peter R Kufahl; Natali E Nemirovsky; Kaveish Sewalia; Megan Grabenauer; Brian F Thomas; Julie A Marusich; Scott Wegner; M Foster Olive
Journal:  Addict Biol       Date:  2012-07-11       Impact factor: 4.280

8.  Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.

Authors:  Noelia Granado; Sara Ares-Santos; Idaira Oliva; Esther O'Shea; Eduardo D Martin; M Isabel Colado; Rosario Moratalla
Journal:  Neurobiol Dis       Date:  2011-02-15       Impact factor: 5.996

9.  1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.

Authors:  Peter C Meltzer; David Butler; Jeffrey R Deschamps; Bertha K Madras
Journal:  J Med Chem       Date:  2006-02-23       Impact factor: 7.446

Review 10.  Methamphetamine and MDMA (ecstasy) neurotoxicity: 'of mice and men'.

Authors:  Yossef Itzhak; Cindy Achat-Mendes
Journal:  IUBMB Life       Date:  2004-05       Impact factor: 3.885

View more
  81 in total

1.  Reinforcing and neurochemical effects of the "bath salts" constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats.

Authors:  Charles W Schindler; Eric B Thorndike; Steven R Goldberg; Kurt R Lehner; Nicholas V Cozzi; Simon D Brandt; Michael H Baumann
Journal:  Psychopharmacology (Berl)       Date:  2015-08-29       Impact factor: 4.530

Review 2.  Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

Authors:  Christopher L German; Annette E Fleckenstein; Glen R Hanson
Journal:  Life Sci       Date:  2013-08-02       Impact factor: 5.037

3.  Locomotor Stimulant and Rewarding Effects of Inhaling Methamphetamine, MDPV, and Mephedrone via Electronic Cigarette-Type Technology.

Authors:  Jacques D Nguyen; Shawn M Aarde; Maury Cole; Sophia A Vandewater; Yanabel Grant; Michael A Taffe
Journal:  Neuropsychopharmacology       Date:  2016-06-09       Impact factor: 7.853

4.  Age-dependent MDPV-induced taste aversions and thermoregulation in adolescent and adult rats.

Authors:  Andrew P Merluzzi; Zachary E Hurwitz; Maria A Briscione; Jennifer L Cobuzzi; Bradley Wetzell; Kenner C Rice; Anthony L Riley
Journal:  Dev Psychobiol       Date:  2013-10-04       Impact factor: 3.038

5.  Investigation of "bath salts" use patterns within an online sample of users in the United States.

Authors:  Patrick S Johnson; Matthew W Johnson
Journal:  J Psychoactive Drugs       Date:  2014 Nov-Dec

Review 6.  Baths salts, spice, and related designer drugs: the science behind the headlines.

Authors:  Michael H Baumann; Ernesto Solis; Lucas R Watterson; Julie A Marusich; William E Fantegrossi; Jenny L Wiley
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

7.  Discriminative-stimulus effects of second generation synthetic cathinones in methamphetamine-trained rats.

Authors:  Jennifer E Naylor; Kevin B Freeman; Bruce E Blough; William L Woolverton; Sally L Huskinson
Journal:  Drug Alcohol Depend       Date:  2015-02-11       Impact factor: 4.492

8.  Contribution of monoaminergic mechanisms to the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone (MDPV) in Sprague-Dawley rats.

Authors:  Harmony I Risca; Lisa E Baker
Journal:  Psychopharmacology (Berl)       Date:  2018-12-15       Impact factor: 4.530

9.  Effects of orally self-administered bath salt constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice.

Authors:  Brenda M Gannon; Lauren N Russell; Meet S Modi; Kenner C Rice; William E Fantegrossi
Journal:  Drug Alcohol Depend       Date:  2017-08-04       Impact factor: 4.492

Review 10.  Neurotoxicology of Synthetic Cathinone Analogs.

Authors:  Mariana Angoa-Pérez; John H Anneken; Donald M Kuhn
Journal:  Curr Top Behav Neurosci       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.